ANARELLA DIAZ: Open Payments
NPI 1811426349 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 19 payments from 8 companies in 2025. Trend: 2023 $352 · 2024 $604 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $43 |
| Medtronic, Inc. | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Exact Sciences Corporation | 1 | $26 |
| Organon LLC | 1 | $22 |
| Amgen Inc. | 1 | $17 |
Products named: Ozempic, Kerendia, ONYX FRONTIER, AIRSUPRA, LINZESS, Cologuard Collection Kit, NEXPLANON, OTEZLA.
Industry payments across CA — which companies pay providers there.
